A total of 5831 men participated in this survey. Face-to-face interviews were used to collect data. Age, mobility, self-care ability, comorbidities and smoking were included as potential risk factors. The type of UI was assessed with the Urogenital Distress Inventory-6 questionnaire. To provide representative population prevalence estimates, the

sample population was weighted by age. Results: The age-adjusted prevalence of Korean male UI was 5.5%. Urgency urinary incontinence was the most prevalent incontinence type. Men aged 65 years and older had a rate of UI eight times that of men aged 19–44 years. Men with problems in mobility or self-care had an OR of 2.3 and 1.7, Cilomilast respectively. Conclusion: The age-adjusted prevalence of UI in community-dwelling Korean men was 5.5%, which is lower than that of Korean women and higher than previously reported prevalence of Korean male incontinence. Age, immobility, and self-care

ability were risk factors for male UI. “
“Objectives: Bladder outlet obstruction (BOO)-related detrusor hypertrophy is associated with upregulation of Rho-kinase (ROCK) activity in an experimental animal model, and has been implicated in BOO-induced bladder dysfunction. The aim of this study was to test whether chronic oral administration of an oral ROCK inhibitor, fasudil (HA1077, 5-isoquinolinesulfonyl homopiperazine), could prevent the development of both detrusor hypertrophy and detrusor overactivity in rat model. Methods: Thirty five-week-old male Sprague-Dawley rats from were divided into three groups (n Selleckchem CHIR-99021 = 10 per

group): control (sham surgical) with no treatment (group 1); 6-week obstructed rats (group 2); and 6-week obstructed rats treated for 6 weeks with fasudil (group 3). Results: The BOO group showed increased detrusor overactivity. Treatment with fasudil partly but significantly ameliorated the development of detrusor overactivity. The expression of RhoA protein in detrusor muscle was significantly greater in the BOO group than in the control group and subsequently decreased with fasudil treatment in the BOO-induced rat. Conclusion: These findings suggest that fasudil, a specific inhibitor of Rho-kinase, ameliorates BOO-induced detrusor overactivity in a rat model. Thus, ROCK inhibitor might be used as a novel agent to treat overactive bladder symptoms. “
“There is accumulated evidence that spontaneous contractions (SCs) in the bladder wall are associated with afferent nerve firing in the bladder. The role of the urothelium in bladder sensation might be restricted to pathological conditions, such as interstitial cystitis or chemical cystitis in which the release of urothelium-derived mediators such as adenosine triphosphate is increased.